Comparison · NCT02351934-fa43e2ce
Furosemide + Enhanced Recovery After Surgery (ERAS) vs Enhanced Recovery After Surgery (ERAS): Number of Participants Requiring Nasogastric Tube Placement
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Furosemide + Enhanced Recovery After Surgery (ERAS) vs Enhanced Recovery After Surgery (ERAS): Number of Participants Requiring Nasogastric Tube Placement. Trial comparisons, record NCT02351934-fa43e2ce. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02351934-fa43e2ce
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0968 | 0.0451 | 0.195 | wilson | |
| Risk in group 2 | 0.0164 | 0.0029 | 0.0872 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0804 | -0.00726 | 0.18 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 5.9 | 0.732 | 47.6 | log | |
| Odds ratio, group 1 over group 2 | 6.43 | 0.75 | 55.1 | log | |
| Number needed to treat, for one more participant with the outcome on Furosemide + Enhanced Recovery After Surgery (ERAS) than on Enhanced Recovery After Surgery (ERAS) | 12.4 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Furosemide + Enhanced Recovery After Surgery (ERAS) | Furosemide 10 mg IV on post-operative day #1 and/or 2, plus ERAS, as described in other arm. | 6 | 62 | OG000 |
| Group 2 | Enhanced Recovery After Surgery (ERAS) | ERAS included administration of celecoxib and gabapentin in the pre-operative setting, single-injection intrathecal analgesic administration immediately prior to induction of general anesthesia, post-operative administration of scheduled acetaminophen and nonsteroidal anti-inflammatory drug (NSAID) or tramadol, and discontinuation of IV fluids by 0800 on postoperative day (POD) 1. Intraoperative fluid administration was dependent on the individual anesthesia provider with no unified commitment to either zero balance or goal-directed fluid therapy. Fluid status was determined based on patient weight. Patients were weighed preoperatively and daily post-operatively using either a bed scale or a unit-based scale. | 1 | 61 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants Requiring Nasogastric Tube Placement
- Description
- Time frame
- Up to 7 days
- Population
- Intention to Treat Analysis
Source ClinicalTrials.gov
Trial
- Title
- Early Diuresis Following Colorectal Surgery
- NCT number
- NCT02351934
- Phases
- PHASE4
- Conditions
- Colorectal Disorders
- Interventions
- Furosemide, Celecoxib, Gabapentin
- Lead sponsor
- Mayo Clinic
- Results first posted
- 2017-06-27
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02351934?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02351934-fa43e2ce